BILI— AI Stock Forecast & Price Targets
Published 7/17/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live BILI price forecast →
Bilibili offers a compelling fundamental setup — four consecutive profitable quarters, gross margins near 37%, a fresh $300M buyback, and a forward P/E of ~14x against a consensus target of $28.67 — but remains technically broken (-24% below 200-day SMA) with a binary August 20 earnings print ~34 days away. The stock has begun a nascent recovery (+9.8% above 20-day, +6.5% weekly, RSI 61) that the AI forecast extends toward $23-24 on the daily horizon, but past bull targets have consistently failed to print. Accumulate patiently around $17-18 support ahead of earnings; do not chase.
Neutral-to-constructive tactically: price is in an early recovery with momentum reclaiming short-term MAs, but the August 20 earnings print (~34 days out) is a hard binary. Do NOT size a swing trade into that print. If already long, hold; if flat, small starter positions on pullbacks to $17.50-$18.00 are acceptable but leave dry powder. Invalidation: a close below $17.00 breaks the emerging recovery structure and reopens $15.79 lows. First resistance $20.00; taking partial profits into $19.50-$20.00 pre-earnings is prudent risk management given IV crush and gap risk. Earnings stance: do NOT add into the print — position size should already be established or deferred until post-print.
1-6 month view is where the thesis lives. If August earnings prints revenue growth >8-10% Y/Y and gross margin holding ≥36.5%, the setup for a re-rating from 14x to 17-18x forward P/E is credible, targeting $22-24. Miss scenarios (margin regression, revenue deceleration) likely retest $15-16 support. Buyback pace, potential resumption of DAU/MAU growth commentary, and any advertising-share commentary are the specific catalysts to monitor. Would change my mind: (1) sustained gross margin below 36% for two consecutive quarters, (2) breakdown below $15 support, (3) any China ADR regulatory escalation.
1-3 year terminal thesis rests on Bilibili completing the transition from growth-at-any-cost to a self-funding, profitable content-and-community platform monetizing a sticky young-Chinese-user base through ads, VAS, and games. If gross margin can push toward 40%+ and operating margin toward 10-15%, forward EPS could scale toward $2.50-3.00, supporting a $30-40 share price at reasonable multiples. Biggest structural risks: (1) China consumer/advertising secular deceleration, (2) ADR delisting or forced conversion pathway, (3) competitive pressure from Douyin/Kuaishou compressing user time-spent. The setup rhymes with prior Chinese internet re-rating stories but demands patience and staged accumulation.
Bilibili has now delivered four consecutive profitable quarters (Q1'26 net income CNY 210M, Q4'25 CNY 513M, Q3'25 CNY 470M, Q2'25 CNY 219M), validating the operating-leverage thesis. Gross margin is stable at ~37% (Q1'26: 37.1%), a meaningful improvement driven by mix shift toward higher-margin advertising and value-added services. TTM revenue of CNY 30.8B is growing ~11% Y/Y with EPS Y/Y TTM of +336%, indicating the profitability inflection is real, not a one-quarter fluke. The balance sheet is solid: CNY 6.6B cash, CNY 9.6B debt (D/E 0.61), current ratio 1.35, and operating cash flow was CNY 2.0B in Q2'25. Capital allocation has clearly turned shareholder-friendly with the new $300M buyback (June 24) following a prior completed $200M program — a direct EPS tailwind. What's working: margin expansion, GAAP profitability, buyback cadence, forward P/E of 14.2x vs. consensus PEG of 0.57. What's less clean: Q1'26 sequential dip vs. the Q4'25 peak (revenue -10% Q/Q, net income -59% Q/Q) reveals leverage is improving but not linear, and ROE at 9.4% and operating margin at 4.1% still leave room to prove sustainability.
The multi-timeframe picture is a classic 'improving but broken' setup. On the weekly chart, price has round-tripped from $34 highs earlier this year down to $16 lows and is grinding sideways near $18, still -47.8% off the 52-week high of $36.40 and -24% below the 200-day SMA. On the daily chart, however, a clear near-term reversal is underway: price bounced from ~$16 in late June, reclaimed the 20-day (+9.79%) and 50-day (+3.57%) SMAs, and RSI at 60.9 shows momentum without being overextended. The 1h and 4h charts show a decisive break above the $18 level with the forecast band projecting $18.68 (1h) and $23.54 (4h) with the daily forecast reaching $24.57 — an aggressive extension. Critical caveat: the 1-week forecast has historically been BEATEN by the naive baseline (discount heavily), and prior bull targets on this name have consistently failed to print. Support: $17.00 / $15.79 (52W low). Resistance: $20 (round number + prior consolidation), then $23-24 (200-day SMA zone). Structural trend reversal is NOT yet confirmed — that requires reclaiming and holding the 200-day.
The dominant fundamental catalyst is the June 24 authorization of a new $300M share repurchase program running through 2028, following completion of the prior $200M program (an incremental ~$31M was already deployed by June 30). This is a concrete, quantifiable EPS tailwind on a ~$6.4B market cap and signals management confidence into the earnings print. Coverage from Insider Monkey framing BILI as a 'cheap stock about to explode' is retail-oriented narrative noise but is directionally consistent with the value case (P/S 1.48, PEG 0.57). The June 17 AGM passed all proposed resolutions — housekeeping, no new information. No China-ADR regulatory escalations in the news flow, which is a silent positive but the tail risk remains dormant, not resolved.
- New $300M buyback program (June 24, 2026) — direct EPS accretion on a ~$6.4B market cap; ~$31M already deployed in the first week
- Gross margin trajectory holding at 37% for four consecutive quarters — validates high-margin ads/VAS mix shift
- Sustained GAAP profitability (four straight quarters) with EPS Y/Y TTM of +336% and forward EPS growth of +26%
- Q1'26 EBITDA of CNY 261M and TTM EBITDA of CNY 3.3B (EV/EBITDA 21.5) — operating leverage compounding
- Analyst consensus target $28.67 (+51% from spot) with a recom of 1.30 (strong buy skew) reflecting Street confidence in the profitability arc
- August 20 earnings is a binary event with gap-and-IV-crush risk; a margin/revenue miss likely retests $15-17 support
- Technical structure remains broken — price -24% below 200-day SMA, YTD -22.7%, no confirmed trend reversal yet
- Q1'26 sequential softness (revenue -10% Q/Q, net income -59% Q/Q) suggests operating leverage is not perfectly linear
- China ADR regulatory/delisting tail risk remains a dormant but real overhang independent of fundamentals
- Short interest at 6.04% of float and short ratio of 6.8 days indicate persistent skeptic base
- Model's 1-week directional accuracy (83%) trails the naive baseline (100%) — the bullish extension to $23-24 should be heavily discounted
- Prior bull targets on this name have systematically failed to print — anchor scenarios conservatively
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord